Aramis Completes Enrollment of its Phase II Clinical Trial Evaluating A197
03 Nov 2022 //
GLOBENEWSWIRE
Aramis Bio Announces 1st Patient Dosed in Phase II Clinical Trial for A197
28 Feb 2022 //
GLOBENEWSWIRE
FDA Clears Aramis Bio`s IND Application for A197 in Dry Eye Disease
11 Jan 2022 //
GLOBENEWSWIRE